Ginkgo Bioworks Holdings DNA
NYSE DNA
$6.80 -0.14 (-2.09%)
As of: Sep 9, 2026 · 3:59 PM EDT

Ginkgo Bioworks Holdings (DNA) Gross Margin Growth (3y) (2023 - 2026)

Analysis

Ginkgo Bioworks Holdings (DNA) Gross Margin Growth (3y) (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (3y) (Qtr)
1 Iqvia Holdings 42.77 Bn 40.69 Bn 1.44 Bn -162.00
2 Medpace Holdings 16.50 Bn 16.00 Bn 201.64 Mn 153.00
3 Charles River Laboratories International 13.37 Bn 13.18 Bn 452.07 Mn 738.00
4 Icon 12.49 Bn 11.56 Bn 479.29 Mn -601.00
5 Fortrea Holdings 1.58 Bn 1.42 Bn 139.20 Mn -104.00
6 Evotec SE 642.83 Mn 216.96 Mn - -
7 Ginkgo Bioworks Holdings 422.55 Mn 338.02 Mn 18.44 Mn 1,393.00
8 Champions Oncology 69.16 Mn 69.16 Mn 7.03 Mn 692.00
9 MindWalk Holdings 59.83 Mn 51.55 Mn 1.82 Mn 119.00
10 VivoSim Labs 1.45 Mn 1.45 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1,393.00
Mar 31, 2026 1,182.00
Dec 31, 2025 -806.00
Sep 30, 2025 1,608.00
Jun 30, 2025 2,876.00
Mar 31, 2025 3,522.00
Dec 31, 2024 3,784.00
Sep 30, 2024 1,310.00
Jun 30, 2024 1,403.00
Mar 31, 2024 696.00
Dec 31, 2023 2,262.00
Sep 30, 2023 81.00